Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by PharmaJet

< Previous 1 2 Next >
Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care
From PharmaJet
Via Business Wire
Publication in Vaccine Highlights Fewer Adverse Events with PharmaJet Needle-free Intradermal Delivery compared to Needle and Syringe
From PharmaJet
Via Business Wire
PharmaJet® Presents Partner Data Demonstrating that Needle-free Delivery Boosts Immune Response of DNA and Novel Therapeutic Cancer Vaccines
From PharmaJet
Via Business Wire
Publication in npj Vaccines Reports Cross-reactive and Long-Lasting Immune Responses for self-amplifying mRNA (samRNA) COVID-19 Vaccine Booster Administered Intradermally with PharmaJet Tropis®
From PharmaJet
Via Business Wire
WHO Deploys Tropis®, PharmaJet’s Needle-free Injection System in Latest Polio Eradication Campaign in Pakistan
From PharmaJet
Via Business Wire
PharmaJet to Highlight Benefits of Needle-free Intradermal Delivery at Medical Conference in Ethiopia
From PharmaJet
Via Business Wire
CORRECTING and REPLACING Publication in NPJ Vaccines Highlights Benefits of Stratis® Intramuscular Delivery of DNA Vaccine for Hantaviruses
From PharmaJet
Via Business Wire
Poster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine Delivery
From PharmaJet
Via Business Wire
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology Solutions
From PharmaJet
Via Business Wire
PharmaJet Announces Implementation Study Results: Increased Coverage, Cost Savings, and Preference for Routine Polio Immunization with Tropis® ID Needle-free Delivery
From PharmaJet
Via Business Wire
Improving Vaccine Performance Using PharmaJet Needle-Free Precision Delivery Technologies: World Vaccine Congress Europe Presentation
From PharmaJet
Via Business Wire
Dr. Wouter Latour Joins PharmaJet as Chief Executive Officer
From PharmaJet
Via Business Wire
PharmaJet and Scancell Sign Strategic Partnership Agreement for Development and Commercialization of a Needle-free DNA Vaccine for Advanced Melanoma
From PharmaJet
Via Business Wire
PharmaJet Needle-free System Selected for WHO Polio Immunization Campaign in Somalia
From PharmaJet
Via Business Wire
Nature Publication Highlights the Benefits of Tropis® Intradermal When Used to Administer a First-in-Class Self-Amplifying mRNA Vaccine
From PharmaJet
Via Business Wire
PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1
From PharmaJet
Via Business Wire
First Human Clinical Study to Assess U.S. Department of Defense DNA Vaccine Candidate against Venezuelan Equine Encephalitis Delivered with PharmaJet Precision Delivery Systems.
From PharmaJet
Via Business Wire
Daicel Group Invests in PharmaJet
From PharmaJet
Via Business Wire
PharmaJet, Nigeria’s National Primary Health Care Development Agency, and Health-focused Consortium Begin Implementation of Study Using Tropis® ID for Routine Immunization
From PharmaJet
Via Business Wire
PharmaJet Partner, Scancell, Announces Positive Data from the First Stage of its Phase 2 Trial of Advanced Melanoma DNA Vaccine delivered Needle-free
From PharmaJet
Via Business Wire
Former Pfizer Vaccine Executive Nanette Cocero Joins the PharmaJet Board of Directors
From PharmaJet
Via Business Wire
PharmaJet Tropis Intradermal Delivery System is Now Authorized for Two Nucleic Acid Vaccines
From PharmaJet
Via Business Wire
Marie Mazur Appointed Chair of PharmaJet Board of Directors
From PharmaJet
Via Business Wire
WHO Launching Polio Eradication Campaign in Pakistan Using PharmaJet Precision Delivery System
From PharmaJet
Via Business Wire
PharmaJet Announces Appointment of Nathalie Landry as Chief Scientific Officer
From PharmaJet
Via Business Wire
PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems
From PharmaJet
Via Business Wire
Needle-Free Precision Delivery Systems Boost Immune Response of DNA Vaccines: Comprehensive Scientific Literature Review
From PharmaJet
Via Business Wire
PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster
From PharmaJet
Via Business Wire
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Their Needle-free Precision Delivery Systems
From PharmaJet
Via Business Wire
PharmaJet, Nigeria's National Primary Health Care Development Agency and Health-focused Consortium Launch Assessment of the PharmaJet Tropis Vaccine Delivery System
From PharmaJet
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.